World of DTC Marketing

AUGUST 12, 2022

Such warnings “constitute the pharma response in literally every instance since 1906,” the first drug regulation agency was created, said Dr. Aaron Kesselheim. In 2020 JAMA found that the estimated median capitalized research and development cost per product was $985 million, counting expenditures on failed trials.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

World of DTC Marketing

JUNE 7, 2021

Retail price increases for widely used brand name prescription drugs consistently exceeded the rate of general inflation between 2006 and 2020. In 2020, retail prices for 260 brand-name prescription drugs widely used by older adults increased by an average of 2.9 The post The perfect storm is coming for pharma.

Pharma 187

Pharma Retail Competition Prescription 187

World of DTC Marketing

JANUARY 10, 2022

Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3

Food and Drug Administration 213

Food and Drug Administration Pharma Marketing Food 213

World of DTC Marketing

NOVEMBER 18, 2021

I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.

Pharma 202

Pharma Medicine Prescription Manufacturing 202

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. It should be a warning to other pharma companies. ” Pharma CEOs are compensated on how their products earn money.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

World of DTC Marketing

OCTOBER 21, 2020

3hree: Pharma websites are still a “brief stop,” but the bounce rates continue to be the highest of any industry. Pharma websites are NOT meeting user needs regarding “reasons to believe” that their product is best for them. 8ight: Paid media for pharma products is performing worse than most other industries.

Media 287

Media Pharma Medical Safety 287

Fierce Pharma

JUNE 29, 2023

After an initial rejection in 2020 and a review delay earlier this year, BioMarin’s Roctavian has finally got the FDA go-ahead to introduce a gene therapy for a not-so-rare disorder.

Doctors 320

Doctors FDA 320

World of DTC Marketing

OCTOBER 5, 2021

drug pricing system is filled with confusing numbers , and many entities profit off the flow of drugs, but pharmaceutical companies retain a vast majority of the proceeds” Big pharma IS big business. Big Pharma’s chokehold around the U.S. political system surpasses that of practically any other industry. In other words, the U.S.

Pharma 241

Pharma Insurance Sales Government 241

World of DTC Marketing

JANUARY 14, 2021

Global digital advertising growth is expected to accelerate to about 18% year-over-year during 2021, up from about 10% growth in 2020 — and continue to show annual growth in the low double digits over the next five years, according to Cowen’s 9 th Annual Ad Outlook report. To master digital marketing, pharma needs to be prepared to fail.

Marketing 180

Marketing Pharma Sales Management 180

Pharma Marketing Network

APRIL 28, 2021

Introducing the recipient of the 2020-21 HBA Honorable Mentor Award, Dr. Rod MacKenzie , Chief Development Officer and EVP, Pfizer and the recipient of the 2020-21 HBA STAR Award, Susan Torroella , Chief Operating Officer, ArmadaHealth. Susan Torroella , Chief Operating Officer, ArmadaHealth 2020-21 HBA STAR.

Networking 98

Networking Pharma Marketing 98

World of DTC Marketing

FEBRUARY 1, 2021

SUMMARY: Digital ad spend in pharmaceutical brands is up 111% so far in 2020 and 80% of that money is being thrown away by fraud and the popularity of programmatic advertising. In other words, the money that pharma is throwing into digital is largely wasted. Pharma DTC. A Waste of money?

Pharma 187

Pharma Media Pharmaceutical Management 187

World of DTC Marketing

AUGUST 26, 2020

However, in both surveys, telehealth visits were perceived as more convenient than office visits (47% in May 2019 vs. 56% in June 2020). Back to HCP’s…digitization can’t replace the relationships that pharma reps and MLS people build with doctors. So what is the future of digitization within healthcare?

Pharma reps 237

Pharma reps Pharma Rep Doctors Physicians 237

MedCity News

MARCH 27, 2023

SR One’s new investment fund is its second one since spinning out of GSK in 2020. The firm says it now has more than $1.5 billion in assets under management.

Management 318

Management Biopharma Pharma 318

MedCity News

FEBRUARY 20, 2024

But this Phase 2 failure follows the 2020 clinical trial pause of a different partnered molecule that addresses the same target. Sanofi, which is leading development of the Denali Therapeutics-partnered molecule, disclosed little about the clinical trial results in ALS.

Leads 298

Leads Biopharma Pharma 298

Pharma Marketing Network

APRIL 9, 2025

In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. Pharma brands were forced to adapt rapidly.

Marketing 52

Marketing Pharma Education Healthcare 52

MedCity News

MARCH 31, 2024

Approval of Akebia Therapeutics’ Vafseo is based on additional post-marketing safety data from Japan, where the drug has been used since 2020. The FDA rejected the drug two years ago due to concerns about cardiovascular safety.

FDA 284

FDA Safety Marketing Biopharma 284

Fierce Pharma

DECEMBER 8, 2023

It’s also the first medicine using the revolutionary CRISPR gene-editing system, which earned its inventors a Nobel Prize in 2020 and holds tantalizing potential to cure diseases for which there is no treatment.

FDA 308

FDA Medicine Pharmaceutical 308

Fierce Pharma

DECEMBER 8, 2023

Elizabeth Mily, who replaced BMS’ former M&A czar Paul Biondi back in 2020, is headed for the exit, the company confirmed Friday. Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker. Three years on, Bristol Myers Squibb is bidding adieu to its top dealmaker.

280

280

Fierce Pharma

SEPTEMBER 20, 2024

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday. That changed Friday.

FDA 207

FDA Patients 207

Fierce Pharma

JUNE 26, 2024

The loss of patent protection on Amarin’s sole commercial product Vascepa in 2020 has led to a roller coaster ride for the Dublin-based company over the past few years. Amarin is getting a fresh shot to challenge Hikma Pharmaceuticals’ generic version of its fish oil-derived heart med in the lower courts. business.

Pharmaceutical 243

Pharmaceutical 243

Fierce Pharma

APRIL 8, 2024

The FDA refused to accept Supernus' first approval bid after the company acquired the med in 2020. The third time is decidedly not the charm for Supernus and its Parkinson’s disease infusion pump. | The following year, the agency doled out a complete response letter, dashing Supernus' second try.

FDA 248

FDA 248

World of DTC Marketing

JANUARY 4, 2022

billion in 2020 (2020 U.S. Pharma companies are aware that insurers will rarely say no to new cancer therapies, but increased scrutinization of early approvals is on the horizon. Newly approved cancer drugs cost an average of $10,000 per month, with some as high as $30,000 per month. billion in 2015 and $208.9 population.

Insurance 273

Insurance Transportation Medical Medicine 273

Fierce Pharma

OCTOBER 22, 2024

The 2020-approved breast cancer med booked $17.9 MacroGenics’ first commercial product, breast cancer drug Margenza, is heading off to TerSera Therapeutics through a $40 million hand-off. | million in 2023 sales as it struggled to make a mark in the crowded market.

Sales 214

Sales Marketing 214

Fierce Pharma

FEBRUARY 20, 2024

It’s been 15 years since Genzyme began rationing the Fabry disease treatment Fabrazyme after a shortage caused by contamination at a manufacturing site, marking the start of many years of litigatio | Sanofi's Genzyme was accused of causing injuries after contaminated doses of its Fabry disease drug led to a shortage, during which the company rationed (..)

Manufacturing 147

Manufacturing 147

Fierce Pharma

JUNE 25, 2024

< | The deal with the Israel Tax Authority wraps up pending litigation over taxes payable from 2008 to 2020. With an agreement to make payments totaling $750 million over the next five years, Teva can wipe its slate clean of litigation from Israeli regulators that concerns over a decade's worth of taxes.<

220

220

World of DTC Marketing

JULY 8, 2022

In 2020, over 75% of AbbVie’s’ sales were made to American consumers, yet only 1% of AbbVie’s’ income was reported in the United States for tax purposes. prescription drug sales signals that big pharma will do anything to avoid hurting profits.

Sales 269

Sales Prescription Pharma Manufacturing 269

World of DTC Marketing

NOVEMBER 1, 2021

SUMMARY: According to eMarketer, “in 2020, spending on digital advertising in the healthcare and pharma industry will grow by 14.2% One area I do agree with them is that “healthcare and pharma will make up 7.1% One area I do agree with them is that “healthcare and pharma will make up 7.1% to reach $9.53

Pharma 227

Pharma Doctors Retail Healthcare 227

World of DTC Marketing

DECEMBER 15, 2020

In April 2020, 43.5% When it comes to telehealth, there are endless opportunities to partner with HCPs, but pharma has to be part of the solution and can’t gink in terms of “marketing” to patients. Pharma’s content needs to focus on helping patients rather than selling them.

Doctors 309

Doctors Physicians Patients Pharma 309

Fierce Pharma

DECEMBER 20, 2023

In 2020, Palatin Technologies paid $12 million to regain the rights in North America to its struggling female libido drug Vyleesi. | In 2020, Palatin paid $12 million to regain the rights in North America to its struggling female libido drug Vyleesi.

Medicine 196

Medicine Marketing 196

Fierce Pharma

JULY 6, 2023

GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.

Patients 226

Patients 226

European Pharmaceutical Review

NOVEMBER 3, 2022

Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Key countries. Germany (in second place) and the UK achieved double-digit growth.

Pharma 103

Pharma Manufacturing Competition Pharmaceutical products 103

Fierce Pharma

MAY 16, 2024

After admitting to the crime four years ago, a former Sandoz executive will avoid hard time for his part in a generic drug price-fixing scheme. | Hector Kellum agreed to cooperate with federal investigators in 2020, admitting his part in a massive generics price-fixing scheme that spanned many companies.

196

196

PM360

OCTOBER 28, 2022

Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharma manufacturers. How should leading pharma companies respond? Pharma Responds with Increasingly Complex KAM Strategies. The Importance of Large, Organized Customers.

Key account management 117

Key account management Pharma Management Manufacturing 117

Pharma Pathway

MARCH 1, 2023

Aurobindo Pharma-Walk-In Interviews for B.Sc On 4th Mar’ 2023 @ Aurobindo Pharma Department: Production Qualification: B.Sc Chemistry Experience: Freshers 2020 to 2022 Passouts Gender: Male Only Location: Hyderabad Date: 4th March’ 2023 Time: 09:00 AM to 4: 00 PM Venue Details: VLR Facilitators Pvt.

Pharma 92

Pharma 92

Fierce Pharma

JUNE 30, 2023

The Securities and Exchange Commission (SEC) has revealed insider trading charges against five—including former Alexion Vice President | The SEC has revealed insider trading charges against five—including former Alexion vice president Joseph Dupont and a Massachusetts police chief—who allegedly took advantage of prior knowledge of Alexion’s 2020 acquisition (..)

Pharmaceutical 207

Pharmaceutical 207

European Pharmaceutical Review

AUGUST 23, 2022

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 105

FDA Food and Drug Administration Pharma Pharmaceutical manufacturing 105

Pharma Marketing Network

MARCH 30, 2021

Until the COVID-19 pandemic struck the world in early 2020, pharma had been pretty resistant to the idea of involving the end-customer, or the patient, into their business models. This increased recognition among every day people practically handed pharma the chance to reconsider its direct relationship with patients.

Pharma 98

Pharma Patients Healthcare Provider Healthcare 98